| 
 Título del proyecto  | 
 Coordinador  | 
| 
 Multivalent chemical tools to study GPCR oligomerization  | 
 Miriam Royo  | 
| 
 Gamma-peptides as anti–alzheimer drugs with BBB crossing properties  | 
 Miriam Royo  | 
| 
 Reelin as a potential ADtarget  | 
 Miriam Royo  | 
| 
 Dendritic carbosilane systems as anti-neurodegenerative agents against Parkinson’s disease  | 
 Rafael Gómez Ramírez  | 
| 
 Neural connectivity analysis pre- and post-transcranial magnetic stimulation in patients with neurological diseases  | 
 Roberto Hornero  | 
| 
 Development of non-invasive electrodes for long-term electroencephalography (EEG) recording with application in brain-computer interfaces  | 
 Roberto Hornero  | 
| 
 Genetic analysis of sepsis and intraoperative neuromonitoring for the assessment of postoperative behavioral changes in children  | 
 Roberto Hornero  | 
| 
 Neuromuscular signal analysis to decipher the reorganization of the spinal cord networks controlling the recovery of skilled hand function in rodents  | 
 Raimon Jané  | 
| 
 Electrophysiological signal processing for the assessment of disabling neurological diseases  | 
 Joan F. Alonso López  | 
| 
 Non invasive assessment of Autonomic Nervous System in depression  | 
 Raquel Bailón  | 
| 
 Hyperspectral and OCT imaging of muscle for assessing muscle degeneration and dystrophia in Duchenne disease  | 
 Olga Conde  | 
| 
 Interactive platform for early detection of neurodegenerative diseases  | 
 José Miguel López Higuera  | 
| 
 Interactive tool for early detection of emotional impairments  | 
 José Miguel López Higuera  | 
| 
 Development of monoclonal antibodies against C99 fragment of APP protein and study of its therapeutic properties for the Alzheimer’s disease treatment  | 
 María Pilar Marco, Núria Pascual  | 
| 
 New hybrid nanodevices for targeting senescence-associated diseases  | 
 Ramón Martínez Máñez  | 
| 
 Search for biomarkers of Alzheimer´s disease in serum  | 
 Ramón Martínez Máñez  | 
| 
 Development of human iPS-derived neural cells as effective drug discovery model for Lafora´s Disease  | 
 Ángel Raya  | 
| 
 Validating multifunctional polymeric nanoparticles as novel therapeutic vehicles for Alzheimer's Disease  | 
 Carlos Rodríguez Abreu  | 
| 
 Nanobiotechnological approach to muscular dystrophies therapy by gene delivery based on elastin like recombinamers  | 
 F.Javier Arias (Rodríguez Cabello)  | 
| 
 Quantification of SPECT and PET images in Parkinson’s disease and degenerative parkinsonisms  | 
 Aida Niñerola (Setoain)  | 
| 
 Neurological mechanisms of resilience to Alzheimer´s Disease  | 
 Juan Domingo Gispert (Setoain)  | 
| 
 Validation of a novel PET quantification technique using Monte-Carlo simulations  | 
 Aida Niñerola (Setoain)  | 
| 
 fMRI: memories through music  | 
 Carlos Falcón (Setoain)  | 
| 
 Validation of quantitative susceptibility mapping for cortical iron deposits quantification in Parkinson's disease  | 
 Raúl Tudela (Setoain)  | 
| 
 Non-pharmacological techniques against the caregiver syndrome  | 
 Jordi Aguiló (Villa)  | 
| 
 Assessment of the mental state in prevention of occupational risk  | 
 Jordi Aguiló (Villa)  | 
| Cáncer | Medicina regenerativa | Enfermedades cardiovasculares | Enfermedades infecciosas | 
| Enfermedades neurológicas y mentales | Enfermedades respiratorias | Oftalmología | Enfermedades hepáticas | 
| Enfermedades raras | Enfermedades óseas | Otras |